Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lammert

Showing results (741-750 of 1,090) with videos related to

Pageof 109
Sort By:
Current Medical Research and Opinion|August 25, 2004
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-makingAndrew J Palmer, Stéphane Roze, William J Valentine, et al.
Urogynecology (Philadelphia, Pa.)|May 18, 2026
Quality Improvement Analysis of Operative Regimen on Urinary Tract InfectionsMildrede N Bonglack, Meredith H Carrel-Lammert, Jonathan M Hoehn, et al.
Gut|August 8, 2006
Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 geneH E Wasmuth, A Glantz, H Keppeler, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|April 18, 2020
Analysis of Phonetic Balance in Standard English PassagesAdam C Lammert, Jennifer Melot, Douglas E Sturim, et al.
Current Medical Research and Opinion|August 25, 2004
Validation of the CORE Diabetes Model against epidemiological and clinical studiesAndrew J Palmer, Stéphane Roze, William J Valentine, et al.
Current Medical Research and Opinion|August 25, 2004
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetesAndrew J Palmer, Stéphane Roze, Morten Lammert, et al.
Magma (New York, N.Y.)|April 9, 2013
3T renal (23)Na-MRI: effects of desmopressin in patients with central diabetes insipidusStefan Haneder, Henrik J Michaely, Simon Konstandin, et al.
BMC Medical Genetics|February 16, 2013
Study design of DIACORE (DIAbetes COhoRtE) - a cohort study of patients with diabetes mellitus type 2Lena Dörhöfer, Alexander Lammert, Vera Krane, et al.
Digestive Diseases and Sciences|September 10, 2017
Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatmentJustin Chan, Neliswa Gogela, Hui Zheng, et al.
Breast Cancer Research and Treatment|June 12, 2021
Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial settingYahya Almodallal, Jennifer G Le-Rademacher, Kathryn D Cook, et al.
Pageof 109

Showing results (741-750 of 1,090) with videos related to

Sort By:
Pageof 109
Current Medical Research and Opinion|August 25, 2004
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-makingAndrew J Palmer, Stéphane Roze, William J Valentine, et al.
Urogynecology (Philadelphia, Pa.)|May 18, 2026
Quality Improvement Analysis of Operative Regimen on Urinary Tract InfectionsMildrede N Bonglack, Meredith H Carrel-Lammert, Jonathan M Hoehn, et al.
Gut|August 8, 2006
Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 geneH E Wasmuth, A Glantz, H Keppeler, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|April 18, 2020
Analysis of Phonetic Balance in Standard English PassagesAdam C Lammert, Jennifer Melot, Douglas E Sturim, et al.
Current Medical Research and Opinion|August 25, 2004
Validation of the CORE Diabetes Model against epidemiological and clinical studiesAndrew J Palmer, Stéphane Roze, William J Valentine, et al.
Current Medical Research and Opinion|August 25, 2004
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetesAndrew J Palmer, Stéphane Roze, Morten Lammert, et al.
Magma (New York, N.Y.)|April 9, 2013
3T renal (23)Na-MRI: effects of desmopressin in patients with central diabetes insipidusStefan Haneder, Henrik J Michaely, Simon Konstandin, et al.
BMC Medical Genetics|February 16, 2013
Study design of DIACORE (DIAbetes COhoRtE) - a cohort study of patients with diabetes mellitus type 2Lena Dörhöfer, Alexander Lammert, Vera Krane, et al.
Digestive Diseases and Sciences|September 10, 2017
Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatmentJustin Chan, Neliswa Gogela, Hui Zheng, et al.
Breast Cancer Research and Treatment|June 12, 2021
Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial settingYahya Almodallal, Jennifer G Le-Rademacher, Kathryn D Cook, et al.
Pageof 109